Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1891)	10/16/2003 5:12:11 AM
From: Icebrg	Read Replies (1) of 3044

Dr. David Fontana, PhD., joins Archemix as the Head of Program Management. Dr. Fontana has over 11 years of industrial drug discovery and development experience. Before joining Archemix, Dr. Fontana was at Millennium Pharmaceuticals, where he led an enterprise-wide initiative to build capabilities in strategic project planning and cross-functional processes. Previously, Dr. Fontana led program management for Aventis Pharmaceuticals in the U.S. Should be a sign of the pruning that is on-going at Millennium. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next